PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för gemcitabine. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

87 hits

Bibliografisk träff 2007-01-16

Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.

Giovannetti E, Mey V, Loni L, Nannizzi S, Barsanti G, Savarino G, Ricciardi S, Del Tacca M, Danesi R.

Pharmacol Res · evaluation study; journal article · DOI 10.1016/j.phrs.2007.01.003

Bibliografisk träff 2006-11-13

Mechanism of activation of beta-D-2'-deoxy-2'-fluoro-2'-c-methylcytidine and inhibition of hepatitis C virus NS5B RNA polymerase.

Murakami E, Bao H, Ramesh M, McBrayer TR, Whitaker T, Micolochick Steuer HM, Schinazi RF, Stuyver LJ, Obikhod A, Otto MJ, Furman PA.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.00400-06

Bibliografisk träff 2006-09-01

Treatment of early-stage nonbulky Hodgkin lymphoma.

Straus DJ.

Curr Opin Oncol · review; journal article · DOI 10.1097/01.cco.0000239880.39086.94

Bibliografisk träff 2006-09-01

Intravesical gemcitabine: an update of clinical results.

Hendricksen K, Witjes JA.

Curr Opin Urol · review; journal article · DOI 10.1097/01.mou.0000240310.70582.ce

Bibliografisk träff 2006-05-01

Development of gemcitabine in non-small cell lung cancer: the Italian contribution.

Metro G, Cappuzzo F, Finocchiaro G, Toschi L, Crinò L.

Ann Oncol · review; evaluation study; journal article · DOI 10.1093/annonc/mdj948

Bibliografisk träff 2006-05-01

Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine.

Trodella L, D'Angelillo RM, Ramella S, Cellini F, Ciresa M, Cesario A, Granone P.

Ann Oncol · comparative study; review; evaluation study; journal article · DOI 10.1093/annonc/mdj950

Bibliografisk träff 2006-04-11

High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.

Kirstein MN, Hassan I, Guire DE, Weller DR, Dagit JW, Fisher JE, Remmel RP.

J Chromatogr B Analyt Technol Biomed Life Sci · validation study; journal article · DOI 10.1016/j.jchromb.2006.03.023

Bibliografisk träff 2006-02-28

Dual-color imaging of nascent blood vessels vascularizing pancreatic cancer in an orthotopic model demonstrates antiangiogenesis efficacy of gemcitabine.

Amoh Y, Li L, Tsuji K, Moossa AR, Katsuoka K, Hoffman RM, Bouvet M.

J Surg Res · research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jss.2005.12.028

Bibliografisk träff 2006-01-01

Gemcitabine-related radiation recall in a patient with pancreatic cancer.

Saif MW, Sellers S, Russo S.

Anticancer Drugs · journal article; case reports · DOI 10.1097/01.cad.0000181590.85476.e3

Bibliografisk träff 2005-09-06

The evolution of cancer research and drug discovery at Lilly Research Laboratories.

Pearce HL, Alice Miller M.

Adv Enzyme Regul · historical article; journal article · DOI 10.1016/j.advenzreg.2005.02.017

Bibliografisk träff 2005-09-01

Gemcitabine in the treatment of advanced head and neck cancer.

Raguse JD, Gath HJ, Bier J, Riess H, Oettle H.

Clin Oncol (R Coll Radiol) · clinical trial, phase ii; journal article; case reports · DOI 10.1016/j.clon.2005.05.006

Bibliografisk träff 2005-07-23

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.

Correale P, Fulfaro F, Marsili S, Cicero G, Bajardi E, Intrivici C, Vuolo G, Carli AF, Caraglia M, Del Prete S, Greco E, Gebbia N, Francini G.

Cancer Chemother Pharmacol · clinical trial, phase ii; multicenter study; journal article · DOI 10.1007/s00280-005-1024-1

Bibliografisk träff 2005-07-01

Phase II study of cisplatin-combined schedules as second-line chemotherapy in patients with non-small cell lung cancer.

Veslemes M, Antoniou D, Georgatou N, Giamboudakis P, Dimitroulis J, Katis K, Stathopoulos GP.

Anticancer Res · clinical trial, phase ii; clinical trial; multicenter study; journal article

Bibliografisk träff 2005-06-01

Gemcitabine in metastatic breast cancer.

Heinemann V.

Expert Rev Anticancer Ther · review; journal article · DOI 10.1586/14737140.5.3.429

Bibliografisk träff 2005-03-01

Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-study.

Schmid P, Schweigert M, Beinert T, Flath B, Sezer O, Possinger K.

Invest New Drugs · clinical trial; clinical trial, phase i; journal article · DOI 10.1007/s10637-005-5859-4

Bibliografisk träff 2005-02-01

Role of gemcitabine in cancer therapy.

Toschi L, Finocchiaro G, Bartolini S, Gioia V, Cappuzzo F.

Future Oncol · review; journal article · DOI 10.1517/14796694.1.1.7

Bibliografisk träff 2005-01-01

Antiangiogenic therapy for human pancreatic carcinoma xenografts in nude mice.

Jia L, Zhang MH, Yuan SZ, Huang WG.

World J Gastroenterol · research-article; journal article · DOI 10.3748/wjg.v11.i3.447

Bibliografisk träff 2004-11-01

Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines.

El-Rayes BF, Ali S, Sarkar FH, Philip PA.

Mol Cancer Ther · journal article · DOI 10.1158/1535-7163.1421.3.11

Bibliografisk träff 2004-08-01

Mechanism for induction of hydroxyurea resistance and loss of latent EBV genome in hydroxyurea-treated Burkitt's lymphoma cell line Raji.

Jiang R, Zhang JL, Satoh Y, Sairenji T.

J Med Virol · research support, non-u.s. gov't; journal article · DOI 10.1002/jmv.20130

Bibliografisk träff 2004-08-01

Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.

Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE.

Clin Cancer Res · clinical trial; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1158/1078-0432.ccr-03-0634

Bibliografisk träff 2004-07-01

[Best supportive care of pancreatic carcinoma].

Schoppmeyer K, Mössner J.

Internist (Berl) · review; journal article; english abstract · DOI 10.1007/s00108-004-1222-7

Bibliografisk träff 2004-06-01

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M.

Chemotherapy · clinical trial; journal article · DOI 10.1159/000077886

Bibliografisk träff 2004-05-01

Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.

Giovannetti E, Mey V, Danesi R, Mosca I, Del Tacca M.

Clin Cancer Res · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1158/1078-0432.ccr-03-0520

Bibliografisk träff 2003-09-01

Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside.

Alexander RL, Morris-Natschke SL, Ishaq KS, Fleming RA, Kucera GL.

J Med Chem · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1021/jm020571x

Bibliografisk träff 2003-08-01

Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer.

Harper P.

Semin Oncol · review; journal article · DOI 10.1016/s0093-7754(03)00279-3

Bibliografisk träff 2003-07-01

Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.

Yilmaz B, Kadioğlu YY, Aksoy Y.

J Chromatogr B Analyt Technol Biomed Life Sci · journal article · DOI 10.1016/s1570-0232(03)00211-3

Bibliografisk träff 2003-07-01

A phase I study of gemcitabine combined with vinblastine in patients with solid tumors.

Capuchino I, Suarez ER, del Giglio A.

Tumori · clinical trial; research support, non-u.s. gov't; clinical trial, phase i; journal article · DOI 10.1177/030089160308900409

Bibliografisk träff 2003-05-01

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death.

Arlt A, Gehrz A, Müerköster S, Vorndamm J, Kruse ML, Fölsch UR, Schäfer H.

Oncogene · research support, non-u.s. gov't; journal article · DOI 10.1038/sj.onc.1206390

Bibliografisk träff 2003-04-01

[Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits].

Shiozawa S, Tsuchiya A, Kumazawa K, Ogawa K.

Gan To Kagaku Ryoho · clinical trial; journal article; english abstract

Bibliografisk träff 2003-04-01

[Gemcitabine improved QOL and survival in a case of diffuse malignant pleural mesothelioma].

Kawamata O, Uda M, Mori M, Urakubo N, Hamano R, Oota T.

Gan To Kagaku Ryoho · journal article; english abstract; case reports